-
9:25am • Opening Remarks
-
9:30am • Opening Fireside Chat: Noubar Afeyan, Founder and CEO, Flagship Pioneering; Co-Founder and Chairman, Moderna
-
9:50am • How can the Combination of Agentic and Human Intelligence Transform Drug Discovery, Development, and Diagnostics?
-
10:20am • Panel: Cell & Gene Therapy: Challenges, Trends and Technologies
-
11:00am • Real Sustainability in Drug Manufacturing
-
11:15am • Old Flames: Why Oral Drugs are Still Attractive!
-
11:30am • Building a new leading CDMO for Global Reliable Supply
-
11:45am • Executive Interview: Kevin Conroy, CEO, Exact Sciences
-
12:05pm • Panel: Unlocking the Power of Healthcare Data: Advancing Access and Connectivity to Drive Patient Outcomes
-
12:45pm • Energizer Break
-
1:00pm • Executive Interview: Bahija Jallal, PhD, CEO, Immunocore
-
1:20pm • Panel: Biotech Markets and IPOs: Trends from 2024 and Projections for 2025
-
2:00pm • Unlocking Success in the Biotech Innovation Ecosystem
-
2:20pm • Partner Presentation by Mineralys
-
2:40pm • Panel: End of the Conglomerate Era
-
3:20pm • Partner Presentation
-
3:40pm • Executive Interview: Sean Salmon, EVP & President, Cardiovascular, Medtronic
-
4:00pm • Closing Remarks
-
9:25am • Opening Remarks
-
9:30am • Executive Interview: Victor Bulto, President, Novartis US
-
9:50am • Accelerating Pharmaceutical Processing Innovation Through Artificial Intelligence
-
10:10am • Panel: Our AI future: A Sector-by-Sector Breakdown
-
10:50am • Fireside Chat with Robert Zirkelbach, Chief Public Affairs Officer & Head of Strategic Initiatives, PhRMA
-
11:10am • Executive Interview: Nelson Ambrogio, President of Radiology, Bayer Pharmaceuticals
-
11:30am • The cRDMo Advantage
-
11:45am • New Approaches for Bringing Advanced Biologics to Clinic Faster
-
12:00pm • Scaling Complex Orals to Launch
-
12:15pm • Panel: Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape
-
1:25pm • Energizer Break
-
1:40pm • Panel: Pharma’s Financial Landscape: Revenue Trends, M&A Strategies, and Patent Expirations
-
2:20pm • Innovative Risk-Sharing Models for Biotech Success
-
2:40pm • Fireside Chat: Tolga Tanguler, EVP and Chief Commercial Officer, Alnylam
-
3:00pm • Partner Presentation by RxLogix
-
3:20pm • The Future of Oncology: Key Investment Areas and Advancements in Treatment Methodologies
-
4:00pm • Closing Remarks
